世界の糖鎖生物学（診断＆治療）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glycobiology (Diagnostics and Therapeutics) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3462 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：産業装置

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、糖鎖生物学（診断＆治療）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・糖鎖生物学（診断＆治療）の市場動向 ・企業の競争状況、市場シェア ・糖鎖生物学（診断＆治療）の種類別市場規模と予測2016-2027（診断、治療） ・糖鎖生物学（診断＆治療）の用途別市場規模と予測2016-2027（診療所、病院、その他） ・糖鎖生物学（診断＆治療）の北米市場規模2016-2027（アメリカ、カナダ） ・糖鎖生物学（診断＆治療）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖鎖生物学（診断＆治療）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖鎖生物学（診断＆治療）の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖鎖生物学（診断＆治療）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biomarin Pharmaceutical Inc.、Glycomimetics、Glycan Biosciences Llc、Glycosensors And Diagnostics Llc、Glycotest Inc.） ・結論

Market Analysis and Insights: Global Glycobiology (Diagnostics and Therapeutics) Market
The global Glycobiology (Diagnostics and Therapeutics) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glycobiology (Diagnostics and Therapeutics) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glycobiology (Diagnostics and Therapeutics) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glycobiology (Diagnostics and Therapeutics) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glycobiology (Diagnostics and Therapeutics) market.

Global Glycobiology (Diagnostics and Therapeutics) Scope and Market Size
Glycobiology (Diagnostics and Therapeutics) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glycobiology (Diagnostics and Therapeutics) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnostics
Therapeutics

Segment by Application
Clinic
Hospital
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biomarin Pharmaceutical Inc.
Glycomimetics
Glycan Biosciences Llc
Glycosensors And Diagnostics Llc
Glycotest Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Glycobiology (Diagnostics and Therapeutics) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glycobiology (Diagnostics and Therapeutics) Market Perspective (2016-2027)
2.2 Glycobiology (Diagnostics and Therapeutics) Growth Trends by Regions
2.2.1 Glycobiology (Diagnostics and Therapeutics) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glycobiology (Diagnostics and Therapeutics) Historic Market Share by Regions (2016-2021)
2.2.3 Glycobiology (Diagnostics and Therapeutics) Forecasted Market Size by Regions (2022-2027)
2.3 Glycobiology (Diagnostics and Therapeutics) Industry Dynamic
2.3.1 Glycobiology (Diagnostics and Therapeutics) Market Trends
2.3.2 Glycobiology (Diagnostics and Therapeutics) Market Drivers
2.3.3 Glycobiology (Diagnostics and Therapeutics) Market Challenges
2.3.4 Glycobiology (Diagnostics and Therapeutics) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glycobiology (Diagnostics and Therapeutics) Players by Revenue
3.1.1 Global Top Glycobiology (Diagnostics and Therapeutics) Players by Revenue (2016-2021)
3.1.2 Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Players (2016-2021)
3.2 Global Glycobiology (Diagnostics and Therapeutics) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glycobiology (Diagnostics and Therapeutics) Revenue
3.4 Global Glycobiology (Diagnostics and Therapeutics) Market Concentration Ratio
3.4.1 Global Glycobiology (Diagnostics and Therapeutics) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycobiology (Diagnostics and Therapeutics) Revenue in 2020
3.5 Glycobiology (Diagnostics and Therapeutics) Key Players Head office and Area Served
3.6 Key Players Glycobiology (Diagnostics and Therapeutics) Product Solution and Service
3.7 Date of Enter into Glycobiology (Diagnostics and Therapeutics) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glycobiology (Diagnostics and Therapeutics) Breakdown Data by Type
4.1 Global Glycobiology (Diagnostics and Therapeutics) Historic Market Size by Type (2016-2021)
4.2 Global Glycobiology (Diagnostics and Therapeutics) Forecasted Market Size by Type (2022-2027)

5 Glycobiology (Diagnostics and Therapeutics) Breakdown Data by Application
5.1 Global Glycobiology (Diagnostics and Therapeutics) Historic Market Size by Application (2016-2021)
5.2 Global Glycobiology (Diagnostics and Therapeutics) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glycobiology (Diagnostics and Therapeutics) Market Size (2016-2027)
6.2 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Type
6.2.1 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021)
6.2.2 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027)
6.2.3 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2027)
6.3 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Application
6.3.1 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021)
6.3.2 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027)
6.3.3 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2027)
6.4 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Country
6.4.1 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021)
6.4.2 North America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glycobiology (Diagnostics and Therapeutics) Market Size (2016-2027)
7.2 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type
7.2.1 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021)
7.2.2 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027)
7.2.3 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2027)
7.3 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application
7.3.1 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021)
7.3.2 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027)
7.3.3 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2027)
7.4 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Country
7.4.1 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021)
7.4.2 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size (2016-2027)
8.2 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Type
8.2.1 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2027)
8.3 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Application
8.3.1 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2027)
8.4 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Region
8.4.1 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size (2016-2027)
9.2 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Type
9.2.1 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021)
9.2.2 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027)
9.2.3 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2027)
9.3 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Application
9.3.1 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021)
9.3.2 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027)
9.3.3 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2027)
9.4 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Country
9.4.1 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021)
9.4.2 Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size (2016-2027)
10.2 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Type
10.2.1 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2027)
10.3 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Application
10.3.1 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2027)
10.4 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Country
10.4.1 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biomarin Pharmaceutical Inc.
11.1.1 Biomarin Pharmaceutical Inc. Company Details
11.1.2 Biomarin Pharmaceutical Inc. Business Overview
11.1.3 Biomarin Pharmaceutical Inc. Glycobiology (Diagnostics and Therapeutics) Introduction
11.1.4 Biomarin Pharmaceutical Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
11.1.5 Biomarin Pharmaceutical Inc. Recent Development
11.2 Glycomimetics
11.2.1 Glycomimetics Company Details
11.2.2 Glycomimetics Business Overview
11.2.3 Glycomimetics Glycobiology (Diagnostics and Therapeutics) Introduction
11.2.4 Glycomimetics Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
11.2.5 Glycomimetics Recent Development
11.3 Glycan Biosciences Llc
11.3.1 Glycan Biosciences Llc Company Details
11.3.2 Glycan Biosciences Llc Business Overview
11.3.3 Glycan Biosciences Llc Glycobiology (Diagnostics and Therapeutics) Introduction
11.3.4 Glycan Biosciences Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
11.3.5 Glycan Biosciences Llc Recent Development
11.4 Glycosensors And Diagnostics Llc
11.4.1 Glycosensors And Diagnostics Llc Company Details
11.4.2 Glycosensors And Diagnostics Llc Business Overview
11.4.3 Glycosensors And Diagnostics Llc Glycobiology (Diagnostics and Therapeutics) Introduction
11.4.4 Glycosensors And Diagnostics Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
11.4.5 Glycosensors And Diagnostics Llc Recent Development
11.5 Glycotest Inc.
11.5.1 Glycotest Inc. Company Details
11.5.2 Glycotest Inc. Business Overview
11.5.3 Glycotest Inc. Glycobiology (Diagnostics and Therapeutics) Introduction
11.5.4 Glycotest Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
11.5.5 Glycotest Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Glycobiology (Diagnostics and Therapeutics) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Glycobiology (Diagnostics and Therapeutics) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions (2016-2021)
Table 8. Global Glycobiology (Diagnostics and Therapeutics) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions (2022-2027)
Table 10. Glycobiology (Diagnostics and Therapeutics) Market Trends
Table 11. Glycobiology (Diagnostics and Therapeutics) Market Drivers
Table 12. Glycobiology (Diagnostics and Therapeutics) Market Challenges
Table 13. Glycobiology (Diagnostics and Therapeutics) Market Restraints
Table 14. Global Glycobiology (Diagnostics and Therapeutics) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Players (2016-2021)
Table 16. Global Top Glycobiology (Diagnostics and Therapeutics) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycobiology (Diagnostics and Therapeutics) as of 2020)
Table 17. Ranking of Global Top Glycobiology (Diagnostics and Therapeutics) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Glycobiology (Diagnostics and Therapeutics) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Glycobiology (Diagnostics and Therapeutics) Product Solution and Service
Table 21. Date of Enter into Glycobiology (Diagnostics and Therapeutics) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Type (2016-2021)
Table 25. Global Glycobiology (Diagnostics and Therapeutics) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Glycobiology (Diagnostics and Therapeutics) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Application (2016-2021)
Table 29. Global Glycobiology (Diagnostics and Therapeutics) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biomarin Pharmaceutical Inc. Company Details
Table 62. Biomarin Pharmaceutical Inc. Business Overview
Table 63. Biomarin Pharmaceutical Inc. Glycobiology (Diagnostics and Therapeutics) Product
Table 64. Biomarin Pharmaceutical Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021) & (US$ Million)
Table 65. Biomarin Pharmaceutical Inc. Recent Development
Table 66. Glycomimetics Company Details
Table 67. Glycomimetics Business Overview
Table 68. Glycomimetics Glycobiology (Diagnostics and Therapeutics) Product
Table 69. Glycomimetics Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021) & (US$ Million)
Table 70. Glycomimetics Recent Development
Table 71. Glycan Biosciences Llc Company Details
Table 72. Glycan Biosciences Llc Business Overview
Table 73. Glycan Biosciences Llc Glycobiology (Diagnostics and Therapeutics) Product
Table 74. Glycan Biosciences Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021) & (US$ Million)
Table 75. Glycan Biosciences Llc Recent Development
Table 76. Glycosensors And Diagnostics Llc Company Details
Table 77. Glycosensors And Diagnostics Llc Business Overview
Table 78. Glycosensors And Diagnostics Llc Glycobiology (Diagnostics and Therapeutics) Product
Table 79. Glycosensors And Diagnostics Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021) & (US$ Million)
Table 80. Glycosensors And Diagnostics Llc Recent Development
Table 81. Glycotest Inc. Company Details
Table 82. Glycotest Inc. Business Overview
Table 83. Glycotest Inc. Glycobiology (Diagnostics and Therapeutics) Product
Table 84. Glycotest Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021) & (US$ Million)
Table 85. Glycotest Inc. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Type: 2020 VS 2027
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Application: 2020 VS 2027
Figure 5. Clinic Case Studies
Figure 6. Hospital Case Studies
Figure 7. Other Case Studies
Figure 8. Glycobiology (Diagnostics and Therapeutics) Report Years Considered
Figure 9. Global Glycobiology (Diagnostics and Therapeutics) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Glycobiology (Diagnostics and Therapeutics) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions: 2020 VS 2027
Figure 12. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions (2022-2027)
Figure 13. Global Glycobiology (Diagnostics and Therapeutics) Market Share by Players in 2020
Figure 14. Global Top Glycobiology (Diagnostics and Therapeutics) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycobiology (Diagnostics and Therapeutics) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Glycobiology (Diagnostics and Therapeutics) Revenue in 2020
Figure 16. Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Type (2016-2021)
Figure 17. Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Type (2022-2027)
Figure 18. North America Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2016-2027)
Figure 20. North America Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2016-2027)
Figure 21. North America Glycobiology (Diagnostics and Therapeutics) Market Share by Country (2016-2027)
Figure 22. United States Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2016-2027)
Figure 26. Europe Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2016-2027)
Figure 27. Europe Glycobiology (Diagnostics and Therapeutics) Market Share by Country (2016-2027)
Figure 28. Germany Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Glycobiology (Diagnostics and Therapeutics) Market Share by Region (2016-2027)
Figure 38. China Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2016-2027)
Figure 46. Latin America Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2016-2027)
Figure 47. Latin America Glycobiology (Diagnostics and Therapeutics) Market Share by Country (2016-2027)
Figure 48. Mexico Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Glycobiology (Diagnostics and Therapeutics) Market Share by Country (2016-2027)
Figure 54. Turkey Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Glycobiology (Diagnostics and Therapeutics) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Biomarin Pharmaceutical Inc. Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
Figure 58. Glycomimetics Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
Figure 59. Glycan Biosciences Llc Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
Figure 60. Glycosensors And Diagnostics Llc Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
Figure 61. Glycotest Inc. Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---